Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
2.900
+0.020 (0.69%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Applied DNA Sciences Market Cap
Applied DNA Sciences has a market cap or net worth of $3.75 million as of September 18, 2025. Its market cap has decreased by -80.96% in one year.
Market Cap
3.75M
Enterprise Value
-648.03K
1-Year Change
-80.96%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since February 14, 2005, Applied DNA Sciences's market cap has decreased from $43.53M to $3.75M, a decrease of -91.40%. That is a compound annual growth rate of -11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 3.75M | -64.89% |
| Dec 31, 2024 | 10.67M | 26.43% |
| Dec 29, 2023 | 8.44M | -60.60% |
| Dec 30, 2022 | 21.41M | -28.83% |
| Dec 31, 2021 | 30.09M | 4.33% |
| Dec 31, 2020 | 28.84M | 97.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |